$6.21 0.32 (+5.43%)
11/6/2009 4:00 PM

Allos Therapeutics, Inc. (ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Member Avatar giftofgod (98.32) Submitted: 12/1/2008 1:22:43 AM : Underperform Start Price: $6.95 ALTH Score: +30.62

Regardless of what is in the pipeline, most companies need to have some revenue in order to make a profit. Even if this company gets FDA approval, it takes time and money to market a drug and make a profit.

Report this Post 0 Comments

Featured Broker Partners